Stealth BioTherapeutics Corp(NASDAQ:MITO) 
Stealth BioTherapeutics Corp, a clinical-stage biotechnology company, focuses on the discovery, development, and commercialization of therapies for diseases involving mitochondrial dysfunction. Its lead product candidate, Elamipretide, has the potential to treat rare genetic and common age-related m...
Website: http://www.stealthbt.com
Founded: 2006
Full Time Employees: 29 (May 2021)
Sector: Healthcare
Industry: Biotechnology
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2022-05-20
P
O 0.22
H 0.25
L 0.22
C 0.24
V 427,244
10EMA 0.24
20EMA 0.24
60EMA 0.24
120EMA 0.24
250EMA 0.24